Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com

Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Vor Biopharma
Grafico Azioni Vor Biopharma (NASDAQ:VOR)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Vor Biopharma